Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck Cancer
Public ClinicalTrials.gov record NCT00756951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Safety and Efficacy of SC-07 for the Delay to Onset of Severe Oral Mucositis in Subjects Receiving Chemoradiation Therapy for the Treatment of Cancers of the Head and Neck.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Oral Mucositis (OM) is a painful and debilitating side effect of many of the drug or radiation regiments used to treat cancer. This study examines the investigational drug SCV-07 and it's possible application in treating Oral Mucositis. Studies have shown that SCV-07 can possibly increase a broad immune system response, thus lowering the painful side effects experienced when treated for head and neck cancer. The purpose of this study is to assess the safety and tolerability of SCV-07 and it's ability to delay the onset of Oral Mucositis for patients receiving chemoradiation for head and neck cancer.
Study identification
- NCT ID
- NCT00756951
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2008
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Nov 22, 2009
Started 2008
United States locations
- U.S. sites
- 19
- U.S. states
- 17
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Arizona Oncology Services Foundation | Phoenix | Arizona | 85013 | — |
| University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | — |
| Whittingham Cancer Center | Norwalk | Connecticut | 06856 | — |
| Helen F Graham Cancer Center | Newark | Delaware | 19713 | — |
| University of Illinois at Chicago | Chicago | Illinois | 60612 | — |
| James Graham Brown Cancer Center | Lousiville | Kentucky | 40202 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Washington University in St Louis | St Louis | Missouri | 63110 | — |
| The Nebraska Medical Center | Omaha | Nebraska | 68198 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28203 | — |
| Mid Dakota Clinic | Bismarck | North Dakota | 58501 | — |
| Ohio State University Medical Center | Columbis | Ohio | 43210 | — |
| St Luke's Hospital & Health Network | Bethlehem | Pennsylvania | 18015 | — |
| Temple University | Philadelphia | Pennsylvania | 19140 | — |
| Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00756951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 22, 2009 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00756951 live on ClinicalTrials.gov.